glp 1 agonist zepbound What to do if you miss a dose of GLP-1 New studies suggest GLP-1 drugs

The primary goal of this article is to emphasize the extensive benefits of using GLP-1RAs in treating a broad spectrum of diseases, such as obesity, cardiovascular diseases, non-alcoholic fatty liver disease (NAFLD), neurodegenerative diseases, musculoskeletal inflammation, and various forms of cancer

GLP-1R agonists and perioperative outcomes 1

In these cardiovascular safety trials, in secondary or exploratory analyses, GLP-1 receptor agonists were also shown to reduce macro-albuminuria, an accepted surrogate marker for diabetic kidney disease (DKD), a condition that still represents a major unmet medical need

Marc Jean, DO, FACOG

Explore a complete 2026 guide to GLP-1 receptor agonists, including an updated drug list, indications, dosing basics, side effects, and safety considerations to discuss with your healthcare provider.